Myeloperoxidase Activity, Lipid Profile And Thyroid Function In Patients Who Suffer From Alzheimer’s Disease

• Published in: Revista cubana de investigaciones biomédicas Vol. 38; no. 1
• Main Authors: Rafael Marcel Ranzola, Yania Ramos Rodríguez, Julio Junco Cuesta, Ariel Pérez Truffin, Jorge Cabrera Llano
• Format: Journal Article
• Language: Spanish
• Published: Centro Nacional de Información de Ciencias Médicas. Editorial de Ciencias Médicas (ECIMED) 01-05-2019
• Subjects: alzheimer´s disease; dyslipidemias; lipid profile; myeloperoxidase activity; oxidative stress; thyroid function
• ISSN: 0864-0300; 1561-3011

Alzheimer´s disease increases its global incidence and prevalence, the WHO includes the disease among the main problems in public health today. Cuba is not apart from this reality. Biochemical markers pretends to enhance its early diagnosis. Objective: to determine myeloperoxidase activity (MPO), lipid profile and thyroid function, in patients who suffer from Alzheimer´s disease. Methods: it was a case and control analytic observational study, in patients from the Santa Clara polyclinic. The MPO activity, total cholesterol, LDL-c, HDL-c, total triglycerides, VLDL, total T3 and T4, and TSH were determined in serum of both groups. Results: no association was found between MPO activity and the presence of the disease (p = 0.348).There was an almost absolute predominance of low levels of HDL-c, more evident in cases (0.43mmol/L), the levels of T3 tended to be close to the lower limit of the physiological range (1.46nmol/L), a relevant finding was a general presence of subclinical hypothyroidism (23.75 %), with no significant differences between groups. Conclusions: The Alzheimer´s disease keeps showing its increasing with age and it is more common in females. High levels of LDL-c and low of HDL-c are frequent in the elderly. Higher levels of HDL-c and T3, this last one into the physiological range, act as protectors against the disease. The subclinical hypothyroidism is present and remains hidden in many of the elder with Alzheimer or not. In a high number of patients, coexist Alzheimer´s disease and some diseases from the metabolic syndrome, as dyslipidemias.